Angiogenesis-associated crosstalk between collagens, CXC chemokines, and thrombospondin domain-containing proteins.

Department of Biomedical Engineering, School of Medicine, Johns Hopkins University, Baltimore, MD 21205, USA.
Annals of Biomedical Engineering (Impact Factor: 3.23). 05/2011; 39(8):2213-22. DOI: 10.1007/s10439-011-0325-2
Source: PubMed

ABSTRACT Excessive vascularization is a hallmark of many diseases including cancer, rheumatoid arthritis, diabetic nephropathy, pathologic obesity, age-related macular degeneration, and asthma. Compounds that inhibit angiogenesis represent potential therapeutics for many diseases. Karagiannis and Popel [Proc. Natl. Acad. Sci. USA 105(37):13775-13780, 2008] used a bioinformatics approach to identify more than 100 peptides with sequence homology to known angiogenesis inhibitors. The peptides could be grouped into families by the conserved domain of the proteins they were derived from. The families included type IV collagen fibrils, CXC chemokine ligands, and type I thrombospondin domain-containing proteins. The relationships between these families have received relatively little attention. To investigate these relationships, we approached the problem by placing the families of proteins in the context of the human interactome including >120,000 physical interactions among proteins, genes, and transcripts. We built on a graph theoretic approach to identify proteins that may represent conduits of crosstalk between protein families. We validated these findings by statistical analysis and analysis of a time series gene expression data set taken during angiogenesis. We identified six proteins at the center of the angiogenesis-associated network including three syndecans, MMP9, CD44, and versican. These findings shed light on the complex signaling networks that govern angiogenesis phenomena.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Development and homeostasis of the vascular system requires integrin-promoting endothelial cell adhesion, migration and survival. Nowadays, integrins represent potential targets for pharmacological agents and open new avenues for the control of metastatic spread in the treatment of tumor malignancies. We have already reported that PIVL, a serine protease inhibitor isolated from Macrovipera lebetina venom, displays an anti-tumor effect through the interference with integrin receptor function. Here, we report that PIVL inhibits human vascular endothelial cell adhesion and migration onto fibrinogen and fibronectin in a dose-dependent manner without any cytotoxicity. Furthermore, we show that PIVL increases microtubule dynamic instability in HMEC-1 transfected with EGFP-tagged α-tubulin. Using Matrigel™ and chick chorioallantoic membrane assays, we demonstrate that PIVL exhibits a strong anti-angiogenic effect both in vitro and in vivo. Interestingly, results herein reveal that the potent anti-angiogenic properties of PIVL are mediated by its RGD-like motif ((41)RGN(43)).
    Microvascular Research 08/2014; 95. DOI:10.1016/j.mvr.2014.08.006 · 2.43 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Blood travels throughout the body in an extensive network of vessels - arteries, veins and capillaries. This vascular network is not static, but instead dynamically remodels in response to stimuli from cells in the nearby tissue. In particular, the smallest vessels - arterioles, venules and capillaries - can be extended, expanded or pruned, in response to exercise, ischaemic events, pharmacological interventions, or other physiological and pathophysiological events. In this review, we describe the multi-step morphogenic process of angiogenesis - the sprouting of new blood vessels - and the stability of vascular networks in vivo. In particular, we review the known interactions between endothelial cells and the various blood cells and plasma components they convey. We describe progress that has been made in applying computational modelling, quantitative biology and high-throughput experimentation to the angiogenesis process.
    Journal of Cellular and Molecular Medicine 11/2013; DOI:10.1111/jcmm.12164 · 3.70 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: OBJECTIVE: To explore the mechanisms of osteoarthritis (OA), gene expression profiling was doneon cartilage from mice with surgically-induced OA. We used wild type mice (WT), and mice lacking ADAMTS-5 activity (Adamts5Δcat) where aggrecan loss and cartilage erosion is inhibited, to distinguish betweengene expression changes that are independent of ADAMTS-5 activity and cartilage breakdown. METHODS: Mechanical instability was introduced into 10 week old male mouse knee joints by surgical destabilization of the medial meniscus (DMM).Cartilage from the developing lesion in DMM and corresponding regions in sham-operated joints at 1, 2 and 6 weeks post-surgery was harvested by microdissection, RNA extracted, amplified and hybridized to whole genome microarrays. RESULTS: We show for the first time thatOA-related genes including Ptgs2, Crlf1 and Inhba, and novel genes, such asPhdla2 and Il11are upregulated in WT and Adamts5Δcatmice and are thusindependent of ADAMTS-5 activity, identifying them as possible OA initiation candidates. The altered expression of other genes requires ADAMTS-5 activity including Col10a1,the sentinel marker of cartilage hypertrophy and Wnt/β-catenin pathway genes. Cell death pathway genes are dysregulated and TP53, FOXO4 and XBP1 ER-stress transcriptional networks activated. Analysis of degradome genes identified the upregulation of many proteases, including Mmp3, Capn2 and novel cartilage proteasesPrss46 and Klk8. Comparison with other studies identified 16 genes also dysregulated in rat and human OA as priorities for study. CONCLUSION: This work provides new insights into the sequence of gene dysregulation and molecular basis of cartilage destruction in OA. © 2013 American College of Rheumatology.
    Arthritis & Rheumatology 02/2013; 65(6). DOI:10.1002/art.37900 · 7.48 Impact Factor


Available from
May 21, 2014